(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEDD9 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1314803 6480464 epigallocatechin gallate results in decreased expression of NEDD9 mRNA CTD PMID:16084531 (S)-nicotine increases expression ISO RGD:1314804 6480464 Nicotine results in increased expression of NEDD9 mRNA CTD PMID:17456735 1,2-dimethylhydrazine decreases expression ISO RGD:1314804 6480464 1, 2-Dimethylhydrazine results in decreased expression of NEDD9 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of NEDD9 mRNA CTD PMID:20170705 17beta-estradiol decreases expression ISO RGD:1314803 6480464 Estradiol results in decreased expression of NEDD9 mRNA CTD PMID:16474171 17beta-estradiol affects expression ISO RGD:1314803 6480464 Estradiol affects the expression of NEDD9 mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1314803 6480464 Estradiol results in increased expression of NEDD9 mRNA CTD PMID:19619570 , PMID:31614463 17beta-estradiol multiple interactions ISO RGD:1314803 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NEDD9 mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of NEDD9 mRNA CTD PMID:19619570 , PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314803 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NEDD9 mRNA, [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of NEDD9 mRNA CTD PMID:19619570 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NEDD9 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314803 6480464 Tetrachlorodibenzodioxin results in decreased expression of NEDD9 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314803 6480464 Tetrachlorodibenzodioxin results in increased expression of NEDD9 mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314804 6480464 Tetrachlorodibenzodioxin affects the expression of NEDD9 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NEDD9 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314804 6480464 Tetrachlorodibenzodioxin results in decreased expression of NEDD9 mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314804 6480464 Tetrachlorodibenzodioxin results in increased expression of NEDD9 mRNA CTD PMID:19465110 , PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1314803 6480464 2 more ... CTD PMID:19031421 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NEDD9 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of NEDD9 mRNA CTD PMID:21346803 2-amino-4,6-dinitrotoluene affects expression EXP 6480464 2-amino-4, 6-dinitrotoluene affects the expression of NEDD9 mRNA CTD PMID:21346803 3,4-dichloroaniline decreases expression ISO RGD:1314803 6480464 3, 4-dichloroaniline results in decreased expression of NEDD9 mRNA CTD PMID:24172598 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of NEDD9 mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1314804 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NEDD9 mRNA CTD PMID:26251327 3-methylcholanthrene increases expression ISO RGD:1314803 6480464 Methylcholanthrene results in increased expression of NEDD9 mRNA CTD PMID:16619036 4-hydroxyphenyl retinamide increases expression ISO RGD:1314804 6480464 Fenretinide results in increased expression of NEDD9 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NEDD9 mRNA CTD PMID:24780913 9-cis-retinoic acid increases expression ISO RGD:1314803 6480464 Alitretinoin results in increased expression of NEDD9 mRNA CTD PMID:15982314 acetamide increases expression EXP 6480464 acetamide results in increased expression of NEDD9 mRNA CTD PMID:31881176 actinomycin D multiple interactions ISO RGD:1314803 6480464 Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NEDD9 mRNA] CTD PMID:16688769 aflatoxin B1 increases expression ISO RGD:1314803 6480464 Aflatoxin B1 results in increased expression of NEDD9 mRNA CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NEDD9 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:1314803 6480464 Aflatoxin B1 results in increased methylation of NEDD9 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:1314803 6480464 aflatoxin B2 results in increased methylation of NEDD9 intron CTD PMID:30157460 all-trans-4-oxoretinoic acid increases expression ISO RGD:1314803 6480464 4-oxoretinoic acid results in increased expression of NEDD9 mRNA CTD PMID:15982314 all-trans-retinoic acid multiple interactions ISO RGD:1314803 6480464 Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NEDD9 mRNA] CTD PMID:16688769 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of NEDD9 mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression ISO RGD:1314803 6480464 Tretinoin metabolite results in increased expression of NEDD9 mRNA, Tretinoin results in increased expression of NEDD9 mRNA CTD PMID:15982314 more ... antirheumatic drug increases expression ISO RGD:1314803 6480464 Antirheumatic Agents results in increased expression of NEDD9 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1314803 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NEDD9 mRNA CTD PMID:16934159 benzene increases expression ISO RGD:1314803 6480464 Benzene results in increased expression of NEDD9 mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression ISO RGD:1314803 6480464 Benzo(a)pyrene results in decreased expression of NEDD9 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:1314803 6480464 Benzo(a)pyrene affects the methylation of NEDD9 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1314803 6480464 Benzo(a)pyrene results in increased expression of NEDD9 mRNA CTD PMID:17879257 more ... benzo[a]pyrene increases expression ISO RGD:1314804 6480464 Benzo(a)pyrene results in increased expression of NEDD9 mRNA CTD PMID:21569818 benzo[a]pyrene decreases expression ISO RGD:1314804 6480464 Benzo(a)pyrene results in decreased expression of NEDD9 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1314803 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1314803 6480464 benzo(e)pyrene results in increased methylation of NEDD9 intron CTD PMID:30157460 bisphenol A decreases expression ISO RGD:1314803 6480464 bisphenol A results in decreased expression of NEDD9 mRNA CTD PMID:16474171 , PMID:29275510 bisphenol A decreases methylation ISO RGD:1314803 6480464 bisphenol A results in decreased methylation of NEDD9 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1314804 6480464 bisphenol A results in decreased expression of NEDD9 mRNA CTD PMID:29161229 , PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NEDD9 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases expression ISO RGD:1314804 6480464 bisphenol A results in increased expression of NEDD9 mRNA CTD PMID:26063408 more ... bisphenol A affects expression ISO RGD:1314803 6480464 bisphenol A affects the expression of NEDD9 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol F increases expression ISO RGD:1314804 6480464 bisphenol F results in increased expression of NEDD9 mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1314803 6480464 butyraldehyde results in increased expression of NEDD9 mRNA CTD PMID:26079696 cadmium atom decreases activity ISO RGD:1314804 6480464 Cadmium results in decreased activity of NEDD9 protein CTD PMID:33642518 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of NEDD9 mRNA CTD PMID:22110744 cadmium dichloride increases expression ISO RGD:1314803 6480464 Cadmium Chloride results in increased expression of NEDD9 protein CTD PMID:26220685 cadmium dichloride affects expression ISO RGD:1314803 6480464 Cadmium Chloride affects the expression of NEDD9 mRNA CTD PMID:25596134 cadmium dichloride decreases expression ISO RGD:1314803 6480464 Cadmium Chloride results in decreased expression of NEDD9 mRNA CTD PMID:33770205 caffeine increases phosphorylation ISO RGD:1314803 6480464 Caffeine results in increased phosphorylation of NEDD9 protein CTD PMID:35688186 chloroacetaldehyde decreases expression ISO RGD:1314803 6480464 chloroacetaldehyde results in decreased expression of NEDD9 mRNA CTD PMID:25596134 chloroprene decreases expression ISO RGD:1314804 6480464 Chloroprene results in decreased expression of NEDD9 mRNA CTD PMID:23125180 chlorpromazine decreases expression EXP 6480464 Chlorpromazine results in decreased expression of NEDD9 mRNA CTD PMID:25596134 choline multiple interactions ISO RGD:1314804 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NEDD9 mRNA CTD PMID:20938992 cidofovir anhydrous decreases expression ISO RGD:1314803 6480464 Cidofovir results in decreased expression of NEDD9 mRNA CTD PMID:25596134 cisplatin affects response to substance ISO RGD:1314803 6480464 NEDD9 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin multiple interactions ISO RGD:1314803 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of NEDD9 mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of NEDD9 mRNA] CTD PMID:27392435 cisplatin decreases expression ISO RGD:1314803 6480464 Cisplatin results in decreased expression of NEDD9 mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:1314803 6480464 Cisplatin results in increased expression of NEDD9 mRNA CTD PMID:27594783 clodronic acid decreases expression ISO RGD:1314803 6480464 Clodronic Acid results in decreased expression of NEDD9 mRNA CTD PMID:25596134 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of NEDD9 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1314803 6480464 cobaltous chloride results in decreased expression of NEDD9 mRNA CTD PMID:19320972 , PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of NEDD9 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of NEDD9 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1314803 6480464 Copper Sulfate results in decreased expression of NEDD9 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1314803 6480464 Coumestrol results in decreased expression of NEDD9 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1314803 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1314803 6480464 Asbestos, Crocidolite results in increased expression of NEDD9 mRNA CTD PMID:25351596 crocidolite asbestos affects expression ISO RGD:1314803 6480464 Asbestos, Crocidolite affects the expression of NEDD9 mRNA CTD PMID:25757056 cyclosporin A decreases expression ISO RGD:1314803 6480464 Cyclosporine results in decreased expression of NEDD9 mRNA CTD PMID:20106945 more ... cyclosporin A decreases methylation ISO RGD:1314803 6480464 Cyclosporine results in decreased methylation of NEDD9 promoter CTD PMID:27989131 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of NEDD9 mRNA CTD PMID:25596134 cylindrospermopsin increases expression ISO RGD:1314803 6480464 cylindrospermopsin results in increased expression of NEDD9 mRNA CTD PMID:24921660 dibutyl phthalate increases expression ISO RGD:1314804 6480464 Dibutyl Phthalate results in increased expression of NEDD9 mRNA CTD PMID:21266533 dichloromethane increases expression ISO RGD:1314803 6480464 Methylene Chloride results in increased expression of NEDD9 mRNA CTD PMID:20359517 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of NEDD9 mRNA CTD PMID:21658437 dioxygen decreases expression ISO RGD:1314803 6480464 Oxygen deficiency results in decreased expression of NEDD9 mRNA CTD PMID:25596134 dioxygen increases expression ISO RGD:1314803 6480464 Oxygen deficiency results in increased expression of NEDD9 mRNA CTD PMID:26516004 disodium selenite increases expression ISO RGD:1314803 6480464 Sodium Selenite results in increased expression of NEDD9 mRNA CTD PMID:18175754 diuron decreases expression ISO RGD:1314803 6480464 Diuron metabolite results in decreased expression of NEDD9 mRNA CTD PMID:24172598 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of NEDD9 mRNA CTD PMID:24172598 divanadium pentaoxide affects expression ISO RGD:1314803 6480464 vanadium pentoxide affects the expression of NEDD9 mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:1314803 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1314804 6480464 Doxorubicin results in increased expression of NEDD9 mRNA CTD PMID:19277126 doxorubicin decreases expression ISO RGD:1314803 6480464 Doxorubicin results in decreased expression of NEDD9 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NEDD9 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1314803 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:1314803 6480464 entinostat results in decreased expression of NEDD9 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1314803 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEDD9 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1314803 6480464 entinostat results in increased expression of NEDD9 mRNA CTD PMID:27188386 ethylbenzene increases expression ISO RGD:1314803 6480464 ethylbenzene results in increased expression of NEDD9 mRNA CTD PMID:20359517 etoposide affects response to substance ISO RGD:1314803 6480464 NEDD9 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenofibrate decreases expression ISO RGD:1314803 6480464 Fenofibrate results in decreased expression of NEDD9 mRNA CTD PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of NEDD9 mRNA CTD PMID:25596134 fenthion increases expression ISO RGD:1314804 6480464 Fenthion results in increased expression of NEDD9 mRNA CTD PMID:34813904 ferric oxide increases expression ISO RGD:1314804 6480464 ferric oxide analog results in increased expression of NEDD9 mRNA CTD PMID:24525745 folic acid multiple interactions ISO RGD:1314804 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NEDD9 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1314804 6480464 Folic Acid results in decreased expression of NEDD9 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1314803 6480464 Formaldehyde results in increased expression of NEDD9 mRNA CTD PMID:23649840 geldanamycin increases expression ISO RGD:1314803 6480464 geldanamycin results in increased expression of NEDD9 mRNA CTD PMID:26705709 gemcitabine increases expression ISO RGD:1314803 6480464 Gemcitabine results in increased expression of NEDD9 mRNA CTD PMID:17039268 genistein decreases expression ISO RGD:1314803 6480464 Genistein results in decreased expression of NEDD9 mRNA CTD PMID:16474171 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of NEDD9 mRNA CTD PMID:24915197 GW 501516 multiple interactions ISO RGD:1314803 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of NEDD9 mRNA CTD PMID:16197558 ibuprofen decreases expression EXP 6480464 Ibuprofen results in decreased expression of NEDD9 mRNA CTD PMID:25596134 ibuprofen decreases expression ISO RGD:1314803 6480464 Ibuprofen results in decreased expression of NEDD9 mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:1314803 6480464 Ifosfamide results in decreased expression of NEDD9 mRNA CTD PMID:25596134 indometacin increases expression ISO RGD:1314803 6480464 Indomethacin results in increased expression of NEDD9 mRNA CTD PMID:16984733 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of NEDD9 mRNA CTD PMID:16629162 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of NEDD9 mRNA CTD PMID:16629162 isotretinoin increases expression ISO RGD:1314803 6480464 Isotretinoin results in increased expression of NEDD9 mRNA CTD PMID:15982314 L-methionine multiple interactions ISO RGD:1314804 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NEDD9 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:1314803 6480464 leflunomide results in increased expression of NEDD9 mRNA CTD PMID:28988120 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of NEDD9 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:1314803 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of NEDD9 mRNA CTD PMID:35811015 metformin decreases expression EXP 6480464 Metformin results in decreased expression of NEDD9 mRNA CTD PMID:25596134 methapyrilene increases methylation ISO RGD:1314803 6480464 Methapyrilene results in increased methylation of NEDD9 intron CTD PMID:30157460 methylisothiazolinone increases expression ISO RGD:1314803 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NEDD9 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1314803 6480464 methylmercuric chloride results in increased expression of NEDD9 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:1314803 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA CTD PMID:27188386 mitomycin C affects response to substance ISO RGD:1314803 6480464 NEDD9 protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-acetyl-L-cysteine decreases expression ISO RGD:1314803 6480464 Acetylcysteine results in decreased expression of NEDD9 mRNA CTD PMID:16084531 nickel sulfate increases expression ISO RGD:1314803 6480464 nickel sulfate results in increased expression of NEDD9 mRNA CTD PMID:22714537 nicotine increases expression ISO RGD:1314804 6480464 Nicotine results in increased expression of NEDD9 mRNA CTD PMID:17456735 o-xylene increases expression ISO RGD:1314803 6480464 2-xylene results in increased expression of NEDD9 mRNA CTD PMID:20359517 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NEDD9 mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:1314804 6480464 MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NEDD9 mRNA] CTD PMID:18700144 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NEDD9 mRNA CTD PMID:33387578 perfluorooctanoic acid increases expression ISO RGD:1314803 6480464 perfluorooctanoic acid results in increased expression of NEDD9 mRNA CTD PMID:25868421 phenobarbital multiple interactions ISO RGD:1314804 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NEDD9 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1314804 6480464 Phenobarbital results in increased expression of NEDD9 mRNA CTD PMID:19482888 , PMID:23091169 phenylmercury acetate increases expression ISO RGD:1314803 6480464 Phenylmercuric Acetate results in increased expression of NEDD9 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314803 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1314804 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NEDD9 mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1314804 6480464 Pregnenolone Carbonitrile results in increased expression of NEDD9 mRNA CTD PMID:28903501 propiconazole increases expression ISO RGD:1314804 6480464 propiconazole results in increased expression of NEDD9 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1314803 6480464 Quercetin results in decreased expression of NEDD9 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1314803 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of NEDD9 mRNA CTD PMID:19167446 rotenone increases expression EXP 6480464 Rotenone results in increased expression of NEDD9 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:1314803 6480464 Rotenone results in increased expression of NEDD9 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1314803 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of NEDD9 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1314803 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1314803 6480464 Silicon Dioxide analog results in decreased expression of NEDD9 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1314803 6480464 Silicon Dioxide results in increased expression of NEDD9 mRNA CTD PMID:25351596 sodium arsenite increases expression ISO RGD:1314803 6480464 sodium arsenite results in increased expression of NEDD9 mRNA CTD PMID:22714537 sodium arsenite decreases expression ISO RGD:1314803 6480464 sodium arsenite results in decreased expression of NEDD9 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:1314804 6480464 sodium arsenite results in decreased expression of NEDD9 mRNA CTD PMID:16014739 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of NEDD9 mRNA CTD PMID:22110744 Soman increases expression EXP 6480464 Soman results in increased expression of NEDD9 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:1314803 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NEDD9 mRNA CTD PMID:36139627 sunitinib increases expression ISO RGD:1314803 6480464 Sunitinib results in increased expression of NEDD9 mRNA CTD PMID:31533062 tacedinaline increases expression ISO RGD:1314803 6480464 tacedinaline results in increased expression of NEDD9 mRNA CTD PMID:33770205 tamoxifen increases expression ISO RGD:1314804 6480464 Tamoxifen results in increased expression of NEDD9 mRNA CTD PMID:25123088 temozolomide increases expression ISO RGD:1314803 6480464 Temozolomide results in increased expression of NEDD9 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1314804 6480464 Testosterone deficiency results in increased expression of NEDD9 mRNA CTD PMID:33848595 tetrachloromethane affects expression ISO RGD:1314804 6480464 Carbon Tetrachloride affects the expression of NEDD9 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1314804 6480464 Carbon Tetrachloride results in increased expression of NEDD9 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEDD9 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NEDD9 mRNA CTD PMID:31150632 tetraphene multiple interactions ISO RGD:1314803 6480464 [benz(a)anthracene co-treated with TNF protein] results in increased expression of NEDD9 mRNA CTD PMID:23396138 toluene increases expression ISO RGD:1314803 6480464 Toluene results in increased expression of NEDD9 mRNA CTD PMID:20359517 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of NEDD9 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NEDD9 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:1314803 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NEDD9 mRNA CTD PMID:36139627 trichloroethene increases expression ISO RGD:1314803 6480464 Trichloroethylene results in increased expression of NEDD9 mRNA CTD PMID:20359517 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of NEDD9 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1314803 6480464 trichostatin A results in decreased expression of NEDD9 mRNA CTD PMID:24935251 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of NEDD9 mRNA CTD PMID:30589522 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of NEDD9 mRNA CTD PMID:25596134 trovafloxacin multiple interactions ISO RGD:1314804 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NEDD9 mRNA CTD PMID:18930950 trovafloxacin decreases expression ISO RGD:1314804 6480464 trovafloxacin results in decreased expression of NEDD9 mRNA CTD PMID:35537566 tungsten decreases expression ISO RGD:1314804 6480464 Tungsten results in decreased expression of NEDD9 mRNA CTD PMID:30912803 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of NEDD9 mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:1314803 6480464 Valproic Acid results in increased expression of NEDD9 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1314803 6480464 Valproic Acid affects the expression of NEDD9 mRNA CTD PMID:25979313 vanadium atom increases activity ISO RGD:1314803 6480464 Vanadium results in increased activity of NEDD9 protein CTD PMID:19000753 vanadium(0) increases activity ISO RGD:1314803 6480464 Vanadium results in increased activity of NEDD9 protein CTD PMID:19000753 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NEDD9 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NEDD9 mRNA CTD PMID:20566332 , PMID:23034163 vorinostat decreases expression ISO RGD:1314803 6480464 vorinostat results in decreased expression of NEDD9 mRNA CTD PMID:18769122 vorinostat increases expression ISO RGD:1314803 6480464 vorinostat results in increased expression of NEDD9 mRNA CTD PMID:27188386
